UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in SRPT — Sarepta Therapeutics, Inc.
CIK 861177
NEW YORK, NY
Position in SRPT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,998,249
-$2,028,289 QoQ
Shares Held
222,496
-19.7% QoQ
Ownership
0.211%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 323 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 42%
Shared 0%
None 58%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. SRPT ranks #71 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in SRPT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,998,249 | 222,496 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $6,026,538 | 276,955 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,736,131 | 266,549 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,498,789 | 233,461 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,774,451 | 396,167 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $29,570,479 | 463,342 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $36,392,005 | 299,301 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $33,495,868 | 268,203 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $47,633,998 | 301,481 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $20,846,551 | 161,027 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $15,526,384 | 161,012 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $19,538,479 | 161,182 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $17,944,020 | 156,689 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $21,596,441 | 156,689 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $15,720,771 | 121,321 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $13,272,204 | 120,067 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $10,382,480 | 138,507 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $10,745,012 | 137,545 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $14,835,372 | 164,746 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,441,372 | 102,091 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,685,341 | 111,723 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $15,281,775 | 205,042 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $69,313,558 | 406,555 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $55,593,284 | 395,879 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $63,420,719 | 395,539 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $44,592,122 | 455,859 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||